Logo XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Companies
  3. hematologic malignancies
Show results for
Products
Services

Companies

News
Articles
Downloads

Refine by
Locations

  • USA
  • Canada
  • Europe

  • Africa
  • Asia & Middle East
  • Australasia
  • Latin America
  • North America
Business Types

  • Manufacturer
  • Technology
Industries served

  • Medical / Health Care
  • Chemical & Pharmaceuticals
  • Monitoring and Testing
  • Water and Wastewater
  • University / Academia / Research
  • Food and Beverage
Employees

  • Over 1000

Hematologic Malignancies Suppliers & Manufacturers

23 companies found

Foundation Medicine, Inc.

Foundation Medicine, Inc.

based inCambridge, MASSACHUSETTS (USA)
Foundation Medicine was founded in 2010 with a mission to bring deep molecular information to the point of care for every patient living with advanced cancer. We’re an essential partner to patients, physicians, researchers, and biopharma ...
Comprehensive Genomic Profiling Tests Services

Comprehensive Genomic Profiling Tests Services

Discover tissue AND blood-based FDA-approved comprehensive genomic profiling testing for all solid tumors with FoundationOne®CDx and FoundationOne®Liquid CDx. In addition, FoundationOne®Heme is a laboratory developed test for ...
CONTACT SUPPLIER

Immune-Onc Therapeutics, Inc.

Immune-Onc Therapeutics, Inc.

based inPalo Alto, CALIFORNIA (USA)
Immune-Onc is a clinical-stage company developing a novel class of myeloid checkpoint inhibitors. We believe myeloid checkpoints are the next frontier of immunotherapy for cancer. In collaboration with scientists, our research team is among the ...
Immune-Onc - Model IO-202 - (Anti-LILRB4) Mechanisms of Action in Hematologic Malignancies Program

Immune-Onc - Model IO-202 - (Anti-LILRB4) Mechanisms of Action in Hematologic Malignancies Program

Immune-Onc’s lead program is IO-202, an antagonist antibody targeting the myeloid checkpoint LILRB4 (also known as ILT3). Immune-Onc has a Phase I trial underway to evaluate IO-202 as a potential treatment for acute myeloid leukemia (AML) and ...
CONTACT SUPPLIER

Lynx Biosciences, Inc.

Lynx Biosciences, Inc.

based inSan Diego, CALIFORNIA (USA)
Lynx Biosciences, Inc. (LynxBio) is a clinical-stage biotechnology company combining physiologically relevant suspension cell co-culture assays, automated microfluidics, and deep learning analytics with the goal of rapidly advancing drug candidates ...
CONTACT SUPPLIER

Genmab A/S

Genmab A/S

based inCopenhagen V, DENMARK
Founded in 1999 in Copenhagen, Denmark, we are a dual-listed, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. We are led by an experienced ...
Genmab HexaBody - Model CD38 (GEN3014) - Novel Human Monoclonal Antibody

Genmab HexaBody - Model CD38 (GEN3014) - Novel Human Monoclonal Antibody

In June 2019, Genmab entered into an exclusive worldwide license and option agreement with Janssen Biotech Inc. to develop and commercialize HexaBody®-CD38. In preclinical models of hematological malignancies, ...
CONTACT SUPPLIER

LGC SeraCare

LGC SeraCare

based inMilford, MASSACHUSETTS (USA)
SeraCare is a leading partner and supplier of diagnostic quality controls, biological materials, and reagents to in vitro diagnostics developers, clinical laboratories, and life science researchers worldwide. Since the early 1980s, we have supported ...
CONTACT SUPPLIER

MedChemExpress LLC (MCE)

MedChemExpress LLC (MCE)

based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
MedChemExpress - Model Phenethicillin sodium - 30302-52-4

MedChemExpress - Model Phenethicillin sodium - 30302-52-4

Phenethicillin (α-Phenoxyethylpenicillin) sodium is a Penicillin, and has antimicrobial ...
CONTACT SUPPLIER

Boston Pharmaceuticals

Boston Pharmaceuticals

based inCambridge, MASSACHUSETTS (USA)
We are a group of individuals who know that there is a better way to develop drugs. Our business model and broad, science-based portfolio has attracted some of the brightest minds in drug development. Our team brings together more than 300 years of ...
Boston - Model BOS-371 - Potent Monoclonal Antibody

Boston - Model BOS-371 - Potent Monoclonal Antibody

BOS-371 is a highly potent monoclonal antibody targeting the Interleukin-1 Receptor Accessory Protein (IL1RAP), a prevalent tumor associated antigen driving tumor growth and immunosuppression. BOS-371 has also been Fc-engineered to enhance effector ...
CONTACT SUPPLIER

Targazyme, Inc.

Targazyme, Inc.

based inCarlsbad, CALIFORNIA (USA)
TargaZyme is a clinical-stage biotechnology company based in San Diego, CA and focused on the research and development of disruptive and novel, off-the-shelf T-Cell products that are aimed at improving the efficacy of T-cell therapies by delivering ...
CONTACT SUPPLIER

Celyad Oncology

Celyad Oncology

based inMont-Saint-Guibert, BELGIUM
Celyad Oncology is a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. We are developing a diversified pipeline of allogeneic and autologous CAR T cell ...
CONTACT SUPPLIER

AstraZeneca

AstraZeneca

based inCambridge, UNITED KINGDOM
Our business is organised to deliver our strategic priorities sustainably, supporting continued scientific innovation and commercial success. We focus on the discovery, development and commercialisation of prescription medicines in Oncology and ...
Model AZD0466 Phase I - Inhibitor for Haematological Malignancies

Model AZD0466 Phase I - Inhibitor for Haematological Malignancies

Mechanism: BCL2/xL; Area under investigation: haematological malignancies; Date commenced phase: Q4 2019; Estimated Filing Acceptance: US: EU: Japan: China; Additional information: Partnered product. Molecule size: Small molecule; Status ...
CONTACT SUPPLIER

Starton Therapeutics

Starton Therapeutics

based inParamus, NEW JERSEY (USA)
Starton is an emerging clinical-stage biotechnology company transforming standard of care therapies with proprietary dermal delivery technology, so people with cancer can receive continuous treatment to live better, longer. Focused on continuous ...
CONTACT SUPPLIER

Therawis

Therawis

based inMunich, GERMANY
Therawis Pharma GmbH is a privately held, profitable oncology-specialized company with offices located in Munich, Germany, and was founded in April 2014. We provide european-wide support in medical & clinical trial development for therapeutics and ...
CONTACT SUPPLIER

Vor Biopharma

Vor Biopharma

based inCambridge, MASSACHUSETTS (USA)
We are a cell therapy company that combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. Vor, the Norse goddess of wisdom, was known as the careful one. ...
VOR - Model VOR33 and VCAR33 - Cellular Treatment System

VOR - Model VOR33 and VCAR33 - Cellular Treatment System

We believe VOR33 and VCAR33 could be highly synergistic as a Treatment System, potentially enabling prolonged remissions or cures in the post-transplant setting. We intend to investigate the VOR33/VCAR33 Treatment System, entailing VOR33 eHSC ...
CONTACT SUPPLIER

Invivoscribe, Inc.

Invivoscribe, Inc.

based inSan Diego, CALIFORNIA (USA)
Invivoscribe is a global leader in molecular diagnostics, providing a comprehensive range of standardized, CE-marked in vitro diagnostic products and companion diagnostics for hematology-oncology. The company's offerings include research use only ...
IdentiClone - Model IGH + IGK - B-Cell Clonality Assay Kit

IdentiClone - Model IGH + IGK - B-Cell Clonality Assay Kit

The IdentiClone B-Cell Clonality Assay Kit is an in vitro diagnostic tool designed to detect clonal rearrangements in immunoglobulin genes within lymphocyte populations. Utilizing polymerase chain reaction (PCR) technology, this assay targets ...
CONTACT SUPPLIER

Nkarta, Inc.

Nkarta, Inc.

based inSouth San Francisco, CALIFORNIA (USA)
We are dedicated to realizing the potential of natural killer (NK) cells for the treatment of cancer. Our proprietary technology is designed to harness the power of these important pathogen-fighting immune cells and is uniquely capable of enhancing ...
Nkarta - Model NKG2D - NKX101 - Activating Receptor

Nkarta - Model NKG2D - NKX101 - Activating Receptor

OX40 costimulatory domain, CD3ζ signaling moiety, membrane bound ...
CONTACT SUPPLIER

LAVA Therapeutics N.V.

LAVA Therapeutics N.V.

based inUtrecht, NETHERLANDS
At LAVA, we are focused on applying our expertise in gamma-delta T cell engagers. We are building a pipeline of gamma-delta bsTCEs that have applications in both solid and hematologic malignancies. Our lead program, LAVA-051, targets the tumor ...
CONTACT SUPPLIER

Thermo Scientific - LC/MS GC GC/MS

Thermo Scientific - LC/MS GC GC/MS

based in, MASSACHUSETTS (USA)
Thermo Scientific instruments, equipment, software, services and consumables empower scientists to solve for complex analytical challenges in pharmaceutical, biotechnology, academic, government, environmental and industrial research, as well as the ...
CONTACT SUPPLIER

AbelZeta Inc.

AbelZeta Inc.

based inRockville, MARYLAND (USA)
Since the treatment of our first oncology patient in 2015, AbelZeta has been able to build best-in-class and best-in-disease potential pipeline, leading to the licensing of two CD20-directed autologous CAR-Ts to Janssen Biotech in 2023. Our goal is ...
Model C-CAR066 - Hematology Malignancies

Model C-CAR066 - Hematology Malignancies

PRODUCT: C-CAR066. INDICATION: r/r B-NHL. PLATFORM: CAR-T. PRECLINICAL: CD20. IIT²: - PHASE 1/1B: - PHASE 2: - PARTNERS: Johnson & ...
CONTACT SUPPLIER

Kiadis Pharma NV

Kiadis Pharma NV

based inAmsterdam, NETHERLANDS
Founded in 1997, Kiadis Pharma is a fully integrated biopharmaceutical company committed to developing innovative, personalized, next-generation cell-based immunotherapies for patients with life threatening diseases. With headquarters in Amsterdam, ...
CONTACT SUPPLIER

Cytognos S.L.

Cytognos S.L.

based inSalamanca, SPAIN
Cytognos is a Biotech company based in Salamanca with over 20 years of experience at successfully designing, developing, manufacturing and commercializing innovative flow cytometry products for in vitro diagnostics (IVD) and life science research ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About XPRT Media

XPRT is a global industry marketplace and information resource. Online product catalogs, news, articles, events, publications & more.


  • FAQs
  • Company sitemap
  • Category sitemap
XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
Medical XPRT